Combining PASP estimation with serum markers like hypoxia-inducible factor 1-alpha (HIF-1α), endothelin-1 (ET-1), and nitric oxide (NO) could improve diagnostic accuracy for PH, particularly in COPD patients, allowing earlier detection and intervention to reduce or delay PH onset. The gene discussed is HIF1A; the disease is chronic obstructive pulmonary disease.